Your browser doesn't support javascript.
loading
Evaluation of Candidate Theranostics for 227Th/89Zr Paired Radioimmunotherapy of Lymphoma.
Abou, Diane S; Longtine, Mark; Fears, Amanda; Benabdallah, Nadia; Unnerstall, Ryan; Johnston, Hannah; Shim, Kyuhwan; Hasson, Abbie; Zhang, Hanwen; Ulmert, David; Mangin, Floriane; Ozen, Serife; Raibaut, Laurent; Brandès, Stéphane; Meyer, Michel; Chambron, Jean-Claude; Tatum, David S; Magda, Darren; Wahl, Richard L; Thorek, Daniel L J.
Affiliation
  • Abou DS; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Longtine M; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Fears A; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Benabdallah N; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Unnerstall R; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Johnston H; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Shim K; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Hasson A; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Zhang H; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Ulmert D; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.
  • Mangin F; Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université de Bourgogne, Dijon, France.
  • Ozen S; Institut de Chimie de Strasbourg, UMR 7177, CNRS, Université de Strasbourg, Strasbourg, France.
  • Raibaut L; Institut de Chimie de Strasbourg, UMR 7177, CNRS, Université de Strasbourg, Strasbourg, France.
  • Brandès S; Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université de Bourgogne, Dijon, France.
  • Meyer M; Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université de Bourgogne, Dijon, France.
  • Chambron JC; Institut de Chimie de Strasbourg, UMR 7177, CNRS, Université de Strasbourg, Strasbourg, France.
  • Tatum DS; Lumiphore, Inc., Berkeley, California.
  • Magda D; Lumiphore, Inc., Berkeley, California.
  • Wahl RL; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
  • Thorek DLJ; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri; thorek.lab@wustl.edu.
J Nucl Med ; 64(7): 1062-1068, 2023 07.
Article in En | MEDLINE | ID: mdl-37142300
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radioimmunotherapy / Lymphoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Nucl Med Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radioimmunotherapy / Lymphoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Nucl Med Year: 2023 Document type: Article Country of publication: United States